News

Latest news

The first two ICOpre® patents filed

February 1, 2021

Iconovo AB (publ) has filed two ICOpre® patent applications. ICOpre® is Iconovo’s new inhalation platform and builds on novel proprietary technology…

Iconovo aims to reach ambitious goals in 2021

January 28, 2021

Biostock published January 28th an article about Iconovo that can be found in its entirety below Yesterday, Iconovo presented its business goals for…

VD Johan Wäborg presenterar Iconovo på Aktiedagen den 27 januari 2021 (only in Swedish)

January 28, 2021

Bolagspresentation av Iconovo från Aktiedagen den 27 januari 2021. Kontakter Johan Wäborg, VD +46 707 78 51 71 …

Press releases

2026 2025 2024 2023 2022 2021 2020 2019 2018

May 07, 2025, 14:20

News

IR

Swedish

Regulatory

Listing Regulation

Corporate Information

General meeting

Notice

Kallelse till årsstämma i Iconovo AB

May 06, 2025, 18:20

News

IR

English

Correction

Regulatory

Listing Regulation

Report

Annual

Correction: ICONOVO AB PUBLISHES THE ANNUAL REPORT 2024 IN ENGLISH

May 06, 2025, 13:40

News

IR

English

Regulatory

Listing Regulation

Report

Annual

ICONOVO AB PUBLISHES THE ANNUAL REPORT 2024 IN ENGLISH

Apr 25, 2025, 08:15

News

IR

Swedish

Regulatory

Listing Regulation

Report

Annual

ICONOVO AB PUBLICERAR ÅRSREDOVISNING FÖR 2024

Apr 24, 2025, 15:00

News

IR

Swedish

Regulatory

Listing Regulation

Corporate Information

Nomination Committee

Iconovos valberedning föreslår val av två nya styrelseledamöter

Apr 24, 2025, 15:00

News

IR

English

Regulatory

Listing Regulation

Corporate Information

Nomination Committee

Iconovo’s nomination committee proposes election of two new board members

Apr 24, 2025, 08:55

News

IR

Swedish

Regulatory

Listing Regulation

Corporate Information

General meeting

Notice

Kallelse till extra bolagsstämma i Iconovo AB

Apr 24, 2025, 08:39

News

IR

Swedish

Regulatory

MAR

Report

Interim

Q1

KVARTALSRAPPORT Q1 2025

Apr 24, 2025, 08:39

News

IR

English

Regulatory

MAR

Report

Interim

Q1

QUARTERLY REPORT Q1 2025

Apr 24, 2025, 08:37

News

IR

Swedish

Regulatory

MAR

Corporate Action

Shares

Issuance

Iconovo beslutar om företrädesemission av aktier om cirka 36,6 MSEK villkorat av godkännande från extra bolagsstämma

Apr 24, 2025, 08:37

News

IR

English

Regulatory

MAR

Corporate Action

Shares

Issuance

Iconovo resolves on a rights issue of shares of approximately SEK 36.6 million subject to approval by extraordinary general meeting

Apr 24, 2025, 08:35

News

IR

English

Regulatory

MAR

Corporate Action

Other

Iconovo implements organizational changes to increase focus on the commercialization of the company's fully developed inhalation platforms

Apr 24, 2025, 08:35

News

IR

Swedish

Regulatory

MAR

Corporate Action

Other

Iconovo genomför organisationsförändringar för ökat fokus på kommersialiseringen av bolagets färdigutvecklade inhalationsplattformar

Mar 31, 2025, 08:30

News

IR

English

Corporate Action

Other

Iconovo receives new patent for ICOres® in Europe

Mar 31, 2025, 08:30

News

IR

Swedish

Corporate Action

Other

Iconovo erhåller nytt patent för ICOres® i Europa

Mar 03, 2025, 13:42

News

IR

English

Corporate Action

Other

Iconovo receives a grant of SEK 670,000 from Innowwide to target the Japanese market

Mar 03, 2025, 13:42

News

IR

Swedish

Corporate Action

Other

Iconovo erhåller anslag om SEK 670 000 från Innowwide för satsning på den japanska marknaden

Feb 27, 2025, 08:30

News

IR

Swedish

Regulatory

MAR

Report

Interim

Yearend

Bokslutskommuniké 1 januari - 31 december 2024

Feb 27, 2025, 08:30

News

IR

English

Regulatory

MAR

Report

Interim

Yearend

Year-end report 1 January - 31 December 2024

Jan 13, 2025, 08:30

News

IR

English

Corporate Action

Other

Iconovo and Lonza to collaborate on the formulation development of an intranasal biologic